430 related articles for article (PubMed ID: 15302896)
1. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans.
Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA
J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896
[TBL] [Abstract][Full Text] [Related]
2. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
3. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.
Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE
Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524
[TBL] [Abstract][Full Text] [Related]
4. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
5. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.
Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA
Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106
[TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity.
Kurian JR; Longlais BJ; Trepanier LA
Pharmacogenet Genomics; 2007 Aug; 17(8):597-603. PubMed ID: 17622936
[TBL] [Abstract][Full Text] [Related]
7. Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction.
Yang MX; Cederbaum AI
Arch Biochem Biophys; 1996 Jul; 331(1):69-78. PubMed ID: 8660685
[TBL] [Abstract][Full Text] [Related]
8. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
Sacco JC; Trepanier LA
Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (-)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase.
Çelik H; Koşar M; Arinç E
Toxicology; 2013 Jun; 308():34-40. PubMed ID: 23567315
[TBL] [Abstract][Full Text] [Related]
11. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
Clement B; Mau S; Deters S; Havemeyer A
Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
[TBL] [Abstract][Full Text] [Related]
12. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5.
Mahmutoglu I; Kappus H
Mol Pharmacol; 1988 Oct; 34(4):578-83. PubMed ID: 2459594
[TBL] [Abstract][Full Text] [Related]
13. Fractionation of liver microsomes with polyethylene glycol and purification of NADH-cytochrome b5 oxidoreductase and cytochrome b5.
Yang MX; Cederbaum AI
Arch Biochem Biophys; 1994 Dec; 315(2):438-44. PubMed ID: 7986089
[TBL] [Abstract][Full Text] [Related]
14. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
[TBL] [Abstract][Full Text] [Related]
15. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation.
Miura A; Tampo Y; Yonaha M
Biochem Mol Biol Int; 1995 Sep; 37(1):141-50. PubMed ID: 8653076
[TBL] [Abstract][Full Text] [Related]
16. Microsomal NADH-cytochrome b5 reductase of bovine brain: purification and properties.
Tamura M; Yubisui T; Takeshita M
J Biochem; 1983 Nov; 94(5):1547-55. PubMed ID: 6654871
[TBL] [Abstract][Full Text] [Related]
17. The role of microsomal cytochrome b5 in the metabolism of ethanol, drugs and the desaturation of fatty acids.
Ozols J
Ann Clin Res; 1976; 8 Suppl 17():182-92. PubMed ID: 12714
[TBL] [Abstract][Full Text] [Related]
18. 1-Hydroxyethyl radical formation during NADPH- and NADH-dependent oxidation of ethanol by human liver microsomes.
Rao DN; Yang MX; Lasker JM; Cederbaum AI
Mol Pharmacol; 1996 May; 49(5):814-21. PubMed ID: 8622631
[TBL] [Abstract][Full Text] [Related]
19. Identification of cytochrome-b5 reductase as the enzyme responsible for NADH-dependent lucigenin chemiluminescence in human spermatozoa.
Baker MA; Krutskikh A; Curry BJ; Hetherington L; Aitken RJ
Biol Reprod; 2005 Aug; 73(2):334-42. PubMed ID: 15858218
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
